MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Memory disorders"

  • 2019 International Congress

    The Effects of Time-Varying Caloric Vestibular Stimulation Therapy on Cognition Impairment in Parkinson’s Disease

    K. Ade, A. Podlewska, S. Banducci, T. Pellat-Higgins, M. Bodani, M. Sakel, L. Smith, D. Attix, P. Lewitt, D. Wilkinson (Raleigh, NC, USA)

    Objective: To evaluate the potential efficacy of a software-controlled, solid-state, time-varying caloric vestibular stimulation (tvCVS) device for the treatment of cognitive impairment in Parkinson’s disease…
  • 2019 International Congress

    Low doses of scopolamine exacerbates dementia among Drosophila with Parkinson’s disease pathophysiology

    G. Chandran (Mysore, India)

    Objective: To assess the non-inducing doses of scopolamine (SCL) on the memory function of Drosophila previously induced with Parkinson's disease phenotype. Background: A large body…
  • 2019 International Congress

    A comparison of serial position effects between patients with MCI due to Parkinson’s disease and patients with MCI due to Alzheimer’s disease

    A. Meyer, I. Handabaka, MM. Ehrensperger, U. Gschwandtner, F. Hatz, AU. Monsch, RD. Stieglitz, P. Fuhr (Basel, Switzerland)

    Objective: To compare the serial position effects (SPE) between patients with Mild Cognitive Impairment (MCI) due to Parkinson’s disease (PD-MCI) and patients with MCI due…
  • 2019 International Congress

    Mild Cognitive Impairment in Young Onset Parkinson Disease

    A. Troster, C. Schweer (Phoenix, AZ, USA)

    Objective: To identify the prevalence of Parkinson disease mild cognitive impairment (PD-MCI) in a group of persons with young onset Parkinson disease (YOPD) consecutively referred…
  • 2019 International Congress

    Prospective Memory in Parkinson’s Disease: the role of the motor subtypes

    A. D'Iorio, G. Maggi, C. Vitale, D. Di Meglio, L. Trojano, G. Santangelo (Caserta, Italy)

    Objective: In the present study, we evaluated whether deficits in Prospective memory (PM) abilities were present to the same extent in tremor dominant patients with…
  • 2018 International Congress

    Evidence based management of Normal Pressure Hydrocephalus: Lessons and future directions

    A. Mahajan, M. Macki, M. Kaur, M. Novikova, R. Shatz, J. Schwalb (Detroit, MI, USA)

    Objective: To present the methodology and management tree of patients referred to the Henry Ford NPH conference for an evaluation from 2003 to 2017. Background:…
  • 2018 International Congress

    Prospective, home-based assessment of motor symptoms in Parkinson’s disease by mean of the Sleep Fit app: A potential new clinical approach

    P-L. Ratti, F. Faraci, A. Mascheroni, S. Hackethal, C. Ferlito, S. Caverzasio, E-K. Choe, Y. Luo, P-E. Nunes Ferreira, A. Puiatti, A. Kaelin-Lang (Lugano, Switzerland)

    Objective: To investigate the correspondence between subjective data on motor symptoms prospectively collected at home and retrospective, subjective data assessed by structured interview in patients…
  • 2018 International Congress

    The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson’s disease and analysis of relevant factors

    K. Nie, Y. Gao, M. Mei, M. Guo, Z. Huang, L. Wang, J. Zhao, Y. Zhang, L. Wang (Guangzhou, China)

    Objective: To investigate the clinical characteristics, cognitive impairment features, and subgroup types of Parkinson’s disease (PD) patients with mild cognitive impairment and to analyze relevant…
  • 2018 International Congress

    Effect of different normative samples and cut-off values on determination of cognitive impairment in the Parkinson’s Progression Marker Initiative

    K. Wyman-Chick, D. Weintraub, P. Martin, L. Erickson, M. (Saint Paul, MN, USA)

    Objective: Compare cognitive performance in participants with Parkinson Disease (PD) utilizing published normative data versus age-stratified norms from the Parkinson’s Progression Marker Initiative (PPMI) healthy…
  • 2018 International Congress

    Hypertriglyceridemia is associated with Parkinson disease mild cognitive impairment (PD-MCI)

    S. Ng, KY. Tay, X. Huang, NSY. Chia, S. Archaryya, F. Setiawan, ZH. Lu, J. Tan, YL. Ng, MC. Wen, A. Ng, W. Au, EK. Tan, L. Tan (Singapore, Singapore)

    Objective: Our study aimed to characterise Parkinson disease (PD) mild cognitive impairment (PD-MCI) in early PD and to identify biomarkers associated with PD-MCI. Background: Approximately…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley